Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)
NCT03471624
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
270
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis B, Chronic
Interventions
DRUG:
Tenofovir Alafenamide
Sponsor
Stanford University
Collaborators
[object Object]